PHD COURSE ON R&D - DRUG DEVELOPMENT
All about collaboration between academy and industry
 • Mölndal, Sweden (Gothenburg area)

The course is postponed to spring 2024. 

Danish Cardiovascular Academy (DCA) organizing a 2-day course for PhD students and Postdocs that will inform the participants about the drug development process in academia and industry and related industry-academia collaborations.

The course will be held on venue of AstraZeneca (Gothenburg area, Sweden) and organized in form of lectures, scientific presentations, and workshops. 

ORGANIZERS:

Professor Muscha Steckelings, University of Southern Denmark, Denmark

Professor Pernille Laerkegaard Hansen, Executive Director and Head of Cardiovascular, Renal and Metabolism (CVRM), AstraZeneca, Sweden

Professor Chris Rhodes, Chief Scientist, Research and Early Development, CVRM, BioPharmaceuticals R&D, and Chair of AstraZeneca’s postdoc programme, AstraZeneca, Sweden

LINK TO  PROGRAM

Allocation of seats
Please note that you are not guaranteed a seat at the event if you do not meet the target group requirements. Priority is given to early career researchers (PhD-students and Postdoc´s ) employed at Danish research and health-care institutions or in the life science industry. For some events a number of seats may be reserved for international participants employed at research and health-care institutions or in the life science industry. If the event is overbooked, the DCAcademy reserves its right to select participants based on the defined requirements.

No-show fee
Please note that the DCAcademy will charge a no-show fee of 2000 DKK if you do not show up and have not unregistered prior to start.